Sintez

Sintez is one of the largest pharmaceutical companies in Russia, producing active pharmaceutical substances, finished dosage forms, veterinary drugs, and medical products made of polymeric materials. It is a leader in the production of antibiotics in Russia. The company is part of Binnopharm Group.
P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential

Sintez balance sheet

Report period2019 2020 2021 2022 2023 Q2 24
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Total preferered shares
Ordinary share price
Preferered share price

Sintez cash flows

Report period2019 2020 2021 2022 2023 Q2 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
EPS

Sintez multipliers

Report period2019 2020 2021 2022 2023 Q2 24 TTM
P/E
E/P
P/B
P/S
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Sintez profitability

Report period2019 2020 2021 2022 2023 Q2 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Sintez assets
Sintez cash flows
Sintez dividends
0%

Sintez shares

TickerNameTypeNominal valueISINPrice
KSINP:RMSintezPreferred shareRUB 1RU0006571866RUB 35,000
KSIN:RMSintezCommon shareRUB 1RU0009257182RUB 49,620
General information
Company nameSintez
Tags#pharmacy, #moex otc
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business addressg.Kurgan, pr. Konstitucii, d.7
Mailing address640008, g.Kurgan, pr. Konstitucii, d.7
Websitewww.ksintez.ru
Information disclosuree-disclosure.ru